CURRENT ENVIRONMENT FOR INTRODUCING HEALTH TECHNOLOGY ASSESSMENT IN GREECE

Author:

Kani Chara,Kourafalos Vasilios,Litsa Panagiota

Abstract

Objectives: The aim of this study was to describe the current regulatory environment in Greece to evaluate the potential introduction of health technology assessment (HTA) for medicinal products for human use.Methods: Data sources consist of national legislation on pricing and reimbursement of health technologies to identify the potential need of establishing HTA and its relevant structure.Results: The pricing procedure regarding medicinal products for human use is based on an external reference pricing mechanism which considers the average of the three lowest Euorpean Union prices. Currently, a formal HTA procedure has not been applied in Greece, and the only prerequisite used for the reimbursement of medicinal products for human use is their inclusion in the Positive Reimbursement List. To restrict pharmaceutical expenditure, a variety of measures—such as clawback mechanisms, rebates, monthly budget caps per physician, generics penetration targeting—have been imposed, aiming mainly to regulate the price level rather than control the introduction of medicinal products for human use in the Greek pharmaceutical market.Conclusions: Greece has the opportunity to rapidly build capacity, implement, and take advantage of the application of HTA mechanisms by clearly defining the goals, scope, systems, context, stakeholders, and methods that will be involved in the local HTA processes, taking into account the country's established e-prescription system and the recently adapted legislative framework.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy

Reference28 articles.

1. Ministerial Decree C5/63587. Claw back for pharmaceutical expenditure for years 2016, 2017, 2018. Official Gazette 1803 B’; 2015 p. 21279-21280.

2. Ministerial Decree 70519. Paragraph 3-Rebate provisions. Official Gazette 2243 B’; 2014 p. 27991-28066.

3. Key principles for the improved conduct of health technology assessments for resource allocation decisions

4. Applying rapid ‘de-facto’ HTA in resource-limited settings: Experience from Romania

5. Ministerial Decree 62494. Setting prescribing limits for medicinal produtcs. Official Gazette 1920 B’; 2014 p. 24211-24218.

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Estimating a cost-effectiveness threshold for healthcare decision-making in the Greek NHS;Health Policy and Technology;2024-09

2. Implementing a Managed Entry Agreement Framework in Cyprus;Expert Review of Pharmacoeconomics & Outcomes Research;2023-07-23

3. Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece;Expert Review of Pharmacoeconomics & Outcomes Research;2021-09-22

4. Drug Policy in Greece;Value in Health Regional Issues;2018-09

5. When health technology assessment is confidential and experts have no power: the case of Hungary;Health Economics, Policy and Law;2018-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3